The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 01, 2020

Filed:

Aug. 25, 2016
Applicant:

Prothena Biosciences Limited, Dublin, IE;

Inventors:

Robin Barbour, Walnut Creek, CA (US);

Lynn R. Zieske, Livermore, CA (US);

Sarah Hamren, Martinez, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/68 (2006.01); C07K 16/18 (2006.01); G01N 33/50 (2006.01); G01N 33/58 (2006.01); G01N 33/543 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6896 (2013.01); C07K 16/18 (2013.01); G01N 33/502 (2013.01); G01N 33/54326 (2013.01); G01N 33/58 (2013.01); G01N 33/582 (2013.01); C07K 2317/24 (2013.01); C07K 2317/565 (2013.01); G01N 2333/435 (2013.01); G01N 2800/2814 (2013.01);
Abstract

The invention provides methods of detecting alpha-synuclein using a capture antibody and a reporter antibody. The capture antibody binds preferentially to full-length alpha-synuclein phosphorylated at residue 129 (PS129 alpha-synuclein) over unphosphorylated full-length alpha-synuclein. The 11A5 antibody is an example of a suitable capture antibody. The reporter antibody binds to an epitope within residues 40-55 of alpha-synuclein. The 23E8 antibody is an example of such an antibody. Because only a small proportion of alpha-synuclein is phosphorylated high sensitivity of detection below picomolar is advantageous.


Find Patent Forward Citations

Loading…